Speech-Language Pathologists in Washburn, WI Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Ms. Joann Mildred Cahill, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 706 Bratley Dr, Washburn, WI 54891 Phone: 715-373-5621

Lindsay Kay Hunt, M.A. CFY/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 706 Bratley Dr, Washburn, WI 54891 Phone: 715-373-5621    Fax: 715-373-5655

Ms. Brooke Ruberg, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Northern Lights Services Inc, 706 Bratley Drive, Washburn, WI 54891 Phone: 715-373-6425    Fax: 715-373-5655

News Archive

Being overweight or obese during pregnancy increases risk of birth defects, study finds

The risk of babies being born with major birth defects increases, the more overweight or obese a mother is, according to a Swedish study. The authors of the research say their findings "underline the importance of having a maternal BMI in the normal range before pregnancy" and that efforts should be made to encourage women of reproductive age to adopt a healthy lifestyle and obtain a normal body weight before conception.

Roundup: La. lawmakers angry they didn't get to decide on health cuts; New Jersey judges protect selves from health benefit cuts; Detailing Calif. health care budget struggles

Louisiana lawmakers bristled Monday about getting few details and no ability to decide the $523 million in budget cuts Gov. Bobby Jindal's administration has made to health care programs, largely to LSU's safety net health care facilities. Several complained the governor's top leaders weren't explaining the gravity of the slashing and the implications on the LSU network of public hospitals and clinics that care for the poor and uninsured in a state where one in five residents don't have health insurance.

New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

The announcement of a new clinical trial, EXCEL (Evaluation of Xience Prime versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization), that will compare drug-eluting stents to coronary artery bypass graft surgery in patients with left main coronary artery disease, was made today at "Optimizing PCI Outcomes: Evolving Paradigms," a symposium presented by the Cardiovascular Research Foundation.

Ribavirin Biopartners 200mg film-coated tablets granted EU marketing approval

Biopartners GmbH has announced that it has received EU marketing authorization from the European Commission for Ribavirin Biopartners 200mg film-coated tablets. The product is intended for the treatment of chronic hepatitis C infection as part of a combination regimen with peginterferon alfa-2b or interferon alfa-2b.

COVID-19 lockdown linked to improved glycemic control in type 1 diabetes

A new study looks at changes in the glycemic control in patients with diabetes during the lockdowns implemented to deal with the COVID-19 pandemic.

Read more Medical News

› Verified 7 days ago